Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05237_nanopub.RAs9VR-8p6912GXxVaw6_7oa78Eghcs08nsVK5CqQtauA#assertion>. }
Showing items 1 to 14 of
14
with 100 items per page.
- drugbank:DB05237 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05237 label "rhMBL [drugbank:DB05237]" assertion.
- drugbank:DB05237 seeAlso DB05237 assertion.
- drugbank:DB05237 description "rhMBL is a protein therapeutic being developed by Enzon for the prevention and treatment of severe infections in individuals with low levels of Mannose-Binding Lectin (MBL). Over 10 percent of the general population is estimated to be MBL-deficient. Natural MBL has an oligomeric structure (400-700 kDa), built of subunits that contain three identical peptide chains of 32 kDa each. Although MBL can form several oligomeric forms, there are indications that dimers and trimers are not biologically active and at least a tetramer form is needed for activation of complement." assertion.
- drugbank:DB05237 identifier "drugbank:DB05237" assertion.
- drugbank:DB05237 title "rhMBL" assertion.
- drugbank:DB05237 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05237 drugbank_vocabulary:drugbank-id "DB05237" assertion.
- drugbank:DB05237 bio2rdf_vocabulary:x-identifiers.org DB05237 assertion.
- drugbank:DB05237 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05237" assertion.
- drugbank:DB05237 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05237 bio2rdf_vocabulary:identifier "DB05237" assertion.
- drugbank:DB05237 drugbank_vocabulary:x-wikipedia wikipedia:Mannose_binding_lectin assertion.
- drugbank:DB05237 drugbank_vocabulary:x-uniprot uniprot:P11226 assertion.